EUVIMEDEUVIMED entdecken
Crossref

L26/P-048 High-DNA integrity sperm selection using an innovative fluid-walled microfluidic method with sperm guidance mechanisms of rheotaxis and thermotaxis

M. Ferrer Buitrago, J.J. Bataller Sánchez, A. Barberá Alberola, E. Ferrer Robles, P. Muñoz Soriano, V. Antequera Durán, C. Calatayud Lliso, M. Ruiz Jorro

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.384 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von M. Ferrer Buitrago und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question How effectively does a fluid-walled microfluidic methodology select sperm with high DNA integrity, including reduced double-strand breaks DNA fragmentation? Summary answer This novel method selects spermatozoa for ICSI with reduced single- and double-strand DNA fragmentation and lower apoptotic signals compared with conventional DGC. What is known already Emerging data indicate that microfluidic sperm sorting improves sperm motility and morphology, supporting its application in assisted reproductive technologies. Microfluidics is a promising approach for selecting spermatozoa with higher DNA integrity, potentially enhancing fertilisation rates and embryo quality. These benefits are attributed to the avoidance of centrifugation-induced mechanical stress and the biomimetic guidance principles: rheotaxis, thermotaxis, and border-following behaviour. Sperm DNA fragmentation, particularly double-strand breaks (DSBs), is associated with impaired embryo development, reduced implantation, and increased miscarriage rates, underscoring its clinical relevance. We evaluated the efficacy of fluid-walled microfluidics in selecting sperm with high DNA integrity for ICSI. Study design, size, duration This preliminary study analysed ten semen samples in accordance with WHO-VI guidelines. Following liquefaction, each sample was divided into two fractions and processed in parallel using centrifugation density gradients (CDG) and a fluid-walled microfluidics method, based on manually extended microdroplet arrays. The microfluidic condition was performed in 10 replicates to optimise sperm yield. Sperm selected by either CDG or microfluidics were fixed in 4% formaldehyde and subsequently processed for DNA integrity analysis following established protocols. Participants/materials, setting, methods The study included fertility patients participating in our IVF program. Sperm DNA integrity was assessed to compare the CDG and microfluidics groups using immunostaining assays for TUNEL (total DNA fragmentation), γ-H2AX (DNA double-strand breaks) and Caspase-3 (apoptosis). For the microfluidics group, sperm recovery was performed using a prototype ICSI dish (Vitrolife Sweden AB) that integrates a fluid-walled microfluidic system for direct sperm selection during ICSI, which exploits rheotaxis, thermotaxis, and border-following behaviour. Main results and the role of chance Sperm characteristics showed the following total mean values: concentration (59,0 ± 45,3 ×106/ml), progressive motility sperm (48,9 ± 10,9 %), morphology 4,6 ± 2,3 %). We observed a decrease in DNA fragmentation and apoptotic cells in all the samples, resulting in normalisation of all previously pathological measurements (reference values TUNEL <15%; γ-H2AX <9%; Caspase-3 <6%). The mean percentage value of TUNEL positive sperm was significantly higher in the CDG fraction (13,9 ± 6,6 %) compared to the microfluidics fraction (8,2 ± 4,9 %; p-value= 0,001). Similarly, the mean percentage value of γ-H2AX positive sperm was significantly higher in the CDG fraction: 7,5 ± 4,0% versus the microfluidics fraction: 4,0 ± 1,7 % (p-value= 0,023). Lastly, the mean percentage value of Caspase-3 positive sperm also showed significant differences between both fractions: CDG group 8,2 ± 4,9% versus microfluidics group 1,0 ± 1,2 % (p-value= 0,000). The average total cell count of TUNEL and Caspase 3 was 494,0 ± 58,3 (CDG group) and 200,7 ± 126,6 (microfluidics group). Regarding γ-H2AX, the average total cell count was 476,0 ± 126,9 and 161,5 ± 105,2, for CDG and microfluidics groups, respectively. Limitations, reasons for caution Sperm recovery, and subsequently total cell count for the assessment of DNA integrity using the fluid-walled microfluidic system was technically challenging, as the method was originally conceived for ICSI rather than for sperm DNA fragmentation analysis. Wider implications of the findings These findings support the efficacy of this ICSI methodology for its potential application in cases with elevated sperm DNA fragmentation, including DSBs. While single-strand DNA fragmentation can be more readily reduced by conventional methods, this system leverages rheotaxis, thermotaxis, and border-following behaviour to selectively reduce DSBs DNA fragmentation. Trial registration number No

Zitieren

APA

Buitrago, M. F., Sánchez, J. B., Alberola, A. B., Robles, E. F., Soriano, P. M., Durán, V. A., Lliso, C. C., & Jorro, M. R. (2026). L26/P-048 High-DNA integrity sperm selection using an innovative fluid-walled microfluidic method with sperm guidance mechanisms of rheotaxis and thermotaxis. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.384

Vancouver

Buitrago MF, Sánchez JB, Alberola AB, Robles EF, Soriano PM, Durán VA, et al. L26/P-048 High-DNA integrity sperm selection using an innovative fluid-walled microfluidic method with sperm guidance mechanisms of rheotaxis and thermotaxis. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.384

BibTeX
@article{Buitrago2026,
  author = {Buitrago, M. Ferrer and Sánchez, J.J. Bataller and Alberola, A. Barberá and Robles, E. Ferrer and Soriano, P. Muñoz and Durán, V. Antequera and Lliso, C. Calatayud and Jorro, M. Ruiz},
  title = {L26/P-048 High-DNA integrity sperm selection using an innovative fluid-walled microfluidic method with sperm guidance mechanisms of rheotaxis and thermotaxis},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.384}
}
Kostenlos starten →